MMJ Recs

AUGUST 20, 2021

The use of cannabis in scientific research in the US has been at a standstill for the last five decades. The limit on where scientists could access cannabis for research was limited to just one facility at the University of Mississippi. What does federally funded cannabis research mean for medical marijuana development?

Access 52

Access Research and Development Marijuana Chronic Pain 52

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Cannabis Law Report

AUGUST 20, 2021

Swiss Life Sciences Group Plc (SLSG) is pleased to announce its partnership with Switzerland’s leading cannabis and CBD genetics experts, Bio Zu Farm , who have been developing their own cannabis genetics for more than 25 years. This fits with our own strong values and commercial objectives. Hands-down, Bio Zu are the right partners.”.

Research and Development 116

Research and Development Strains Treatment Epilepsy 116

Kind Meds (Cannabis Education Blog)

SEPTEMBER 1, 2020

The cannabis industry is changing rapidly across the United States, and public opinion has shifted significantly over just the last decade that shows increased public support for cannabis reform laws in states that have not already adopted such laws. What Does Available Cannabis Research Tell Us? CBD for Mental Health Treatment.

Treatment 122

Treatment Research and Development CBD THC 122

CannaMD

MARCH 24, 2021

Researchers from Temple University sought to find out how recreational marijuana legalization in Washington and Colorado influenced adolescent treatment admissions for cannabis. MARIJUANA LEGALIZATION & YOUTH DRUG TREATMENT ADMISSIONS. Researchers Jeremy Mennis and Gerald J.

Treatment 104

Treatment Legalization Marijuana Research and Development 104

Veriheal

SEPTEMBER 14, 2021

The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Crescenz VA Medical Center. Their hypothesis was published in the American Journal of Psychiatry.

Consumption 97

Consumption Research and Development Treatment Programs 97

MMJ Recs

OCTOBER 26, 2023

The landscape of medical marijuana laws in the United States is complex and continually evolving. With federal and state regulations, varying laws by state, and ongoing updates, it’s crucial to have a comprehensive understanding of this ever-changing field. Idaho: Idaho has strict marijuana laws and does not have an MMJ program.

Law 98

Law Marijuana Programs Dispensary 98

Cannabis Law Report

FEBRUARY 28, 2022

In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

OCTOBER 7, 2021

We also asked Greg Rovner, CEO of Heally the same series of questions about the hoped for boost to research in Florida. Have you been working with the representatives and/or any other parties to put the legislation together and we’d be especially interested to know if you have worked with any lawyers or law firms on the proposed legislation?

Legislation 105

Legislation Research and Development Treatment Therapy 105

Kind Meds (Cannabis Education Blog)

OCTOBER 19, 2020

However, these treatments have not proven to be wholly effective in managing the symptoms of depression. For some individuals, conventional treatments only worsen the symptoms of depression. This has spurred significantly greater interest in alternative remedies, including using cannabis for mental health treatment.

Treatment 111

Treatment Research and Development Strains THC 111

Cannabis Law Report

OCTOBER 15, 2021

(USOTC: PAOG) cited a British Medical Journal case study report published today on the effectiveness of CBD in the treatment of lung cancer and COPD as validation of PAOG’s ongoing research and development of its own respiratory disorder treatment under the name RespRx. 9,199,960).

Treatment 52

Treatment Research and Development CBD eCommerce 52

Veriheal

JULY 16, 2020

The commission tasked with developing recommendations to improve mental health treatment for veterans concluded: Congress and the executive branch need to promote research into the therapeutic potential of cannabis and psychedelics such as psilocybin mushrooms and MDMA. Research is Limited Due to Many Obstacles.

Research and Development 95

Research and Development Clinical Trials Treatment Compliance 95

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

MMJ Recs

FEBRUARY 3, 2024

In recent years, the landscape of medical marijuana laws has evolved, presenting new opportunities and challenges for patients, healthcare providers, and industry stakeholders. These laws outline the parameters for the cultivation, distribution, and use of medical cannabis within the city.

Legislation 52

Legislation Law Marijuana Dispensary 52

Cannabis Law Report

AUGUST 13, 2021

Derived from Salvia divinorum, SalA is a unique non-nitrogenous agonist of the kappa-opioid receptor (KOR) with potential use in treatment-resistant depression (TRD), substance use disorder (SUD) and pain. Clinically, there are published reports of the potential benefits of Salvia divinorum in the treatment of TRD. BERLIN, Aug.

Conditions 105

Conditions Research and Development Clinical Trials Treatment 105

The Cannigma

JUNE 2, 2023

The government remains steadfast in its commitment to maintaining strict drug laws to ensure public safety. The law unequivocally prohibits the possession, consumption, importation, and trafficking of cannabis. Law enforcement agencies in Singapore actively combat drug offenses. Is weed legal in Singapore?

Law 52

Law Research and Development Consumption Therapy 52

Cannabis Law Report

MAY 26, 2022

Australia’s Commonwealth Scientific and Industrial Research Organisation has been issued a licence to conduct research into psychedelic drug treatments. In an announcement on 18 May, CSIRO said it was moving into the research area to investigate the use of psychedelic drugs in treating mental illness.

Research and Development 52

Research and Development Extraction Treatment Medicine 52

Cannabis Law Report

MARCH 19, 2022

While their votes don’t change state law , the city councils’ decisions make it the lowest priority for police officers to enforce laws related to entheogenic plants or advise that no city official should use public resources to enforce the laws. Read more at [link].

Decriminalization 98

Decriminalization State Laws Law Research and Development 98

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation (POPLAR). The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Background.

Law 59

Law Policy Research and Development Clinical Trials 59

Cannabis Law Report

AUGUST 15, 2021

Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications. The progress Beckley Psytech has made in attracting exceptional talent to the team and advancing our ambitious clinical development programmes over the past two years has been tremendously exciting.

Medicine 98

Medicine Research and Development Conditions Treatment 98

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Additionally, there were several instances in which cepharanthine displayed growth inhibition which was comparable or superior to current gold standard treatments, including colorectal, liver and skin cancers.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

MMJ Recs

DECEMBER 17, 2023

Let’s take a deeper dive into the various MMJ laws in Texas, exploring the regulations, qualifying conditions, dosage guidelines, purchasing options, and access process for medical marijuana in the Lone Star State. Current Texas Medical Marijuana Regulations CBD laws in Texas are governed by the Compassionate Use Program.

Law 52

Law Dispensary Clinical Trials Programs 52

Veriheal

JULY 9, 2021

According to Yale University Professor of Psychiatry Cyril Desouza, where the study was carried out, approximately three out of 10 people are developing a cannabis use disorder. For the past 25 years, Desouza has been investigating the world of cannabinoid treatment options. His most recent bout of research is already two years deep.

Treatment 52

Treatment Research and Development Consumption Sleep 52

Cannabis Law Report

JULY 24, 2021

Argel Aguilar-Valles at Carleton University (“Carleton”) Department of Neuroscience by the Accelerate program at Mitacs for research into the anxiolytic potential of TD-010 in preclinical models of chronic anxiety and depression. Benzodiazepine Dependency.

Research and Development 98

Research and Development Treatment Therapy Media 98

Cannabis Law Report

APRIL 13, 2022

Delic Labs’ latest exemptions enable the Company to develop innovative analytical methods for psychedelic research. Last year, the lab also applied for a Dealer’s License with the intent of commercializing psilocybin research and associated intellectual property (IP) for medical and research purposes.

Research and Development 52

Research and Development Treatment Extraction Medicine 52

Cannabis Law Report

JULY 28, 2021

InnarisBio), to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders. InnarisBio), to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders. A potential solution is direct nose-to-brain delivery.

Research and Development 98

Research and Development Programs Treatment Media 98

Cannabis Law Report

JULY 6, 2021

This collaboration is intended to include research into COMP360 psilocybin therapy and other novel therapies that may be developed by COMPASS in areas of unmet need such as depression, post-traumatic stress disorder (PTSD) and anorexia. This is a really exciting prospect and has the potential to change people’s lives for the better.”.

Research and Development 98

Research and Development Clinical Trials Therapy Patients 98

Cannabis Law Report

JULY 6, 2021

GH Research, a Dublin-based company studying the potential of 5-MeO-DMT for the treatment of psychiatric and neurological disorders, is now listing its stock on the Nasdaq under the symbol “GHRS” after opening for trading on Friday, July 2 at $22. The financing was co-led by RA Capital and RTW Investments, LP, U.S.

Clinical Trials 96

Clinical Trials Research and Development Treatment Therapy 96

Cannabis Law Report

JULY 28, 2021

To date, the clinic network has seen over 75,000 unique patients and has conducted extensive research in cannabinoid therapy as it relates to sleeping disorders, opioid reduction and other topics. General Research: The Company has engaged General Research GmbH (“GR”) to increase its exposure to investors in Europe.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

APRIL 28, 2021

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.

Pharmaceutical 98

Pharmaceutical Data Medicine Treatment 98

Cannabis Law Report

MAY 26, 2022

NEO: AWKN ) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction, announced today the filing of a Patent Cooperation Treaty (PCT) application for the treatment of behavioral addictions with ketamine and ketamine-assisted psychotherapy.

Treatment 52

Treatment Research and Development Therapy Data 52

Cannabis Law Report

AUGUST 7, 2022

The legislation significantly inhibited research into the potential therapeutic uses of psychedelics for decades. But these substances remain illegal under federal law. Where Laws Are Changing. In 2018, the FDA granted COMPASS Pathways BTD to develop psilocybin therapy for treatment-resistant depression.

Law 74

Law Research and Development Therapy Treatment 74

Illinois News Joint

APRIL 27, 2024

Professors and professionals in the cannabis field will deliver research and educational presentations from 12:30-4:20 p.m. Presenters include representatives from Southern Illinois University, Female Orgasm Research Institute, St. Bell teaches Cannabis Law & Entrepreneurship in SLU’s Cannabis Science and Operations program.

Research and Development 98

Research and Development Events Environment Education 98

Cannabis Law Report

APRIL 26, 2021

TEL AVIV, Israel and BETHESDA, Maryland, April 26, 2021 /PRNewswire/ — Cannabics Pharmaceuticals Inc. OTCQB: CNBX), a global leader in… Read More.

Pharmaceutical 59

Pharmaceutical Treatment Programs Cannabis 59

Cannabis Law Report

JULY 29, 2021

We want to be an industry leader in preventing negative side effects during treatment and believe this can be of benefit to the entire industry.” Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question.

Research and Development 105

Research and Development Conditions Data Patients 105